ARTICLE | Finance

Scared off Sequenom

Sequenom stock falls on possible fundraising ahead of Down's Syndrome data

March 22, 2010 7:00 AM UTC

Sequenom Inc. (NASDAQ:SQNM) shareholders got cold feet last week after the company said on its earnings call that it will need to raise money this year - and that it will not necessarily wait for data from its SEQureDx Down Syndrome test to do so.

On the week, Sequenom shares lost $2.53 (32%) to $5.28. The short interest at Feb. 26 was 19.4 million, representing 37.5% of the float...